No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
AHCO240621P7500
- 0.11
- 0.000.00%
15min DelayClose May 31 15:59 ET
0.11High0.11Low
0.11Open0.11Pre Close1 Volume173 Open Interest7.50Strike Price11.00Turnover91.19%IV-22.05%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier18DDays to Expiry0.11Time Value100Contract SizeAmericanOptions Type-0.1065Delta0.0934Gamma86.18Leverage Ratio-0.0094Theta-0.0005Rho-9.18Eff Leverage0.0040Vega
Intraday
- 5D
- 1D
News
Insiders At AdaptHealth Sold US$51m In Stock, Alluding To Potential Weakness
The fact that multiple AdaptHealth Corp. (NASDAQ:AHCO) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. Knowing whether inside
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pro Medicus Limited (OtherPMCUF), AdaptHealth (AHCO) and Verastem (VSTM)
AdaptHealth: A Strong Buy on Impressive EBITDA, Organic Growth, and Strategic Cost Management
Express News | Adapthealth Corp : Leerink Partners Raises Target Price to $14 From $13
AdaptHealth Corp. to Participate in the UBS Healthcare Services Cape Cod Summit
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services,
AdaptHealth Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services,
Comments
$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
6
Despite promising growth forecasts, the company's P/S ratio is lower than expected due to major risk factors. The market shows hesitation about the company, despite high growth forecasted.
AdaptHealth's sales haven't grown significantly despite reinvestment into growth, causing investor concern. Their inconsistent high-growth stock traits suggest better returns elsewhere. The stock drop implies uncertain investor sentiment regarding the firm's future.
Insiders' net selling over the past year clouds the positive signal of high insider ownership levels, calling for investor caution due to associated risks.
Gainers:
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
21
Read more